Lupin Ltd. Purchases Instem Preclinical Software for Novel Drug Discovery & Development Program
Published: May 01, 2012
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Lupin Limited (Lupin) has purchased the Provantis® preclinical software solution. Provantis will be deployed at the Lupin Research Park, the company’s state-of-the art global R&D hub in Pune, India, housing over 1,000 scientists.